Small Pharma Virtually Opens The Market

TORONTO, May 14, 2021 /CNW/ - Peter Rands, Chief Executive Officer, Small Pharma Inc. ("Small Pharma" or "the Company") (TSXV: DMT), and his team joined Dani Lipkin, Director, Global Business Development TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and open the market.

 

Small Pharma is a neuropharmaceutical company specialised in IP led development of novel treatments for mental health conditions, with a focus on depression. Small Pharma initiated a clinical program into DMT assisted therapy in February 2021. This program includes a Phase I/IIa trial on their lead candidate alongside development of a robust pipeline of proprietary preclinical assets. For more information visit https://www.smallpharma.co.uk/.

For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact [e-mail]. The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET

Date:   Friday, May 14, 2021  
Time:   9:00am - 9:30am
Place:  Virtually Broadcast

SOURCE TSX Venture Exchange

Copyright 2021 Canada NewsWire